Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions

Thomas Anchordoquy,Natalie Artzi,Irina V. Balyasnikova,Yechezkel Barenholz,Ninh M. La-Beck,Jacob S. Brenner,Warren C. W. Chan,Paolo Decuzzi,Agata A. Exner,Alberto Gabizon,Biana Godin,Samuel K. Lai,Twan Lammers,Michael J. Mitchell,S. Moein Moghimi,Vladimir R. Muzykantov,Dan Peer,Juliane Nguyen,Rachela Popovtzer,Madison Ricco,Natalie J. Serkova,Ravi Singh,Avi Schroeder,Anna A. Schwendeman,Joelle P. Straehla,Tambet Teesalu,Scott Tilden,Dmitri Simberg
DOI: https://doi.org/10.1021/acsnano.4c00182
IF: 17.1
2024-05-21
ACS Nano
Abstract:In recent years, steady progress has been made in synthesizing and characterizing engineered nanoparticles, resulting in several approved drugs and multiple promising candidates in clinical trials. Regulatory agencies such as the Food and Drug Administration and the European Medicines Agency released important guidance documents facilitating nanoparticle-based drug product development, particularly in the context of liposomes and lipid-based carriers. Even with the progress achieved, it is clear...
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
What problem does this paper attempt to address?